Modulation of serum gastric parietal cell antibody level by levamisole and vitamin B12 in oral lichen planus.

作者: H-P Lin , Y-P Wang , J-S Chia , C-P Chiang , A Sun

DOI: 10.1111/J.1601-0825.2010.01711.X

关键词:

摘要: Oral Diseases (2010) 17, 95–101 Objectives:  The objective of this study was to test the efficacy three different treatment modalities on reduction serum anti-gastric parietal cell autoantibody (GPCA) level in GPCA-positive oral lichen planus (OLP) patients. Materials and methods:  Of 147 OLP patients, 100 were treated with levamisole plus vitamin B12, 10 B12 only 37 only. GPCA levels patients measured at baseline after treatment. Results:  Treatment for a period 2–50 months 4–44 months could effectively reduce high undetectable respectively. However, not modulate mean titer significantly lower patients. A 92% recurrence rate found 25 receiving no further during GPCA-negative remission period. Conclusion:  For modality containing can level. underlying autoimmune atrophic gastritis trait should receive maintenance life.

参考文章(16)
Josip Lukač, Suzana Brozović, Vanja Vučićević-Boras, Marinka Mravak-Stipetić, Branko Malenica, Zvonko Kusić, None, Serum Autoantibodies to Desmogleins 1 and 3 in Patients with Oral Lichen Planus Croatian Medical Journal. ,vol. 47, pp. 53- 58 ,(2006)
Inger M.C. Lundström, Serum immunoglobulins and autoantibodies in patients with oral lichen planus. International Journal of Oral Surgery. ,vol. 14, pp. 259- 268 ,(1985) , 10.1016/S0300-9785(85)80037-5
Song-Chyr Lin, Andy Sun, Ying-Chin Wu, Chun-Pin Chiang, Presence of anti-basal cell antibodies in oral lichen planus. Journal of The American Academy of Dermatology. ,vol. 26, pp. 943- 947 ,(1992) , 10.1016/0190-9622(92)70138-6
J. Hirota, T. Osakiand, Y. Tatemoto, Immunohistochemical staining of infiltrates in oral lichen planus. Pathology Research and Practice. ,vol. 186, pp. 625- 632 ,(1990) , 10.1016/S0344-0338(11)80226-8
M. Carrozzo, S. Gandolfo, G. Lodi, M. Carbone, P. Garzino-Demo, C. Carbonero, S. R. Porter, C. Scully, Oral lichen planus in patients infected or noninfected with hepatitis C virus: the role of autoimmunity Journal of Oral Pathology & Medicine. ,vol. 28, pp. 16- 19 ,(2007) , 10.1111/J.1600-0714.1999.TB01988.X
Tetsuya Yamamoto, Kazunori Yoneda, Eisaku Ueta, Tokio Osaki, Cellular immunosuppression in oral lichen planus. Journal of Oral Pathology & Medicine. ,vol. 19, pp. 464- 470 ,(1990) , 10.1111/J.1600-0714.1990.TB00788.X
Z. Z. Zhao, N. W. Savage, P. B. Sugerman, L. J. Walsh, Mast cell/T cell interactions in oral lichen planus Journal of Oral Pathology & Medicine. ,vol. 31, pp. 189- 195 ,(2002) , 10.1034/J.1600-0714.2002.310401.X
G. Lodi, I. Olsen, A. Piattelli, E. D'Amico, L. Artese, S.R. Porter, Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection Journal of Oral Pathology and Medicine. ,vol. 26, pp. 36- 39 ,(1997) , 10.1111/J.1600-0714.1997.TB00007.X
A. Sun, C-P. Chiang, P-S. Chiou, J-T. Wang, B-Y Liu, Y-C. Wu, Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus Journal of Oral Pathology & Medicine. ,vol. 23, pp. 172- 177 ,(1994) , 10.1111/J.1600-0714.1994.TB01108.X